ONCHealthcareLarge-Cap
BeOne Medicines Ltd. Insider Trading Activity
Every SEC Form 4 insider transaction reported for BeOne Medicines Ltd. (ONC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ONC insiders buying or selling?
BeOne Medicines Ltd. insiders reported 2 open-market buys ($677.9M) and 280 sells ($6.3B) across 282 Form 4 filings — a net selling position of $5.6B.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 17, 2026)
Total Form 4 filings
282
SEC EDGAR
Insider filers
20
Insider buys (2)
$677.9M
Insider sells (280)
$6.3B
Insider sentiment
Net sellingNet insider flow of $5.6B in net selling.
Recent ONC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 64.6K | $312.00 | $20.2M |
| Jul 17, 2026 | John Oyler | Chief Executive Officer | Sale | 283.2K | $315.56 | $89.4M |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 145.9K | $305.95 | $44.6M |
| Jul 15, 2026 | John Oyler | Chief Executive Officer | Sale | 60.2K | $303.18 | $18.3M |
| Jun 25, 2026 | Xiaobin Wu | President and COO | Sale | 1.3K | $276.26 | $356.9K |
| Jun 25, 2026 | John Oyler | Chief Executive Officer | Sale | 3.4K | $273.78 | $933.6K |
| Jun 25, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.1K | $276.74 | $295.6K |
| Jun 18, 2026 | Xiaobin Wu | President and COO | Sale | 1.4K | $266.76 | $362.0K |
| Jun 18, 2026 | John Oyler | Chief Executive Officer | Sale | 3.7K | $265.55 | $980.7K |
| Jun 18, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 590 | $265.98 | $156.9K |
| Jun 18, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.2K | $265.39 | $310.2K |
| Jun 15, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 169 | $257.20 | $43.5K |
| Jun 15, 2026 | Lai Wang | President, Global Head of R&D | Sale | 756 | $261.00 | $197.3K |
| Jun 15, 2026 | Aaron Rosenberg | Chief Financial Officer | Sale | 631 | $257.74 | $162.6K |
| Jun 15, 2026 | Xiaobin Wu | President and COO | Sale | 626 | $261.20 | $163.5K |
| Jun 15, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 428 | $257.64 | $110.3K |
| Jun 15, 2026 | John Oyler | Chief Executive Officer | Sale | 1.9K | $257.24 | $501.4K |
| Jun 10, 2026 | Titus B. Ball | Principal Accounting Officer | Sale | 136 | $271.33 | $36.9K |
| Jun 10, 2026 | Chan Henry Lee | SVP, General Counsel | Sale | 871 | $270.42 | $235.5K |
| Jun 10, 2026 | Lai Wang | President, Global Head of R&D | Sale | 1.4K | $269.38 | $368.2K |
| Jun 10, 2026 | Xiaobin Wu | President and COO | Sale | 1.5K | $269.37 | $399.7K |
| Jun 10, 2026 | John Oyler | Chief Executive Officer | Sale | 4.9K | $270.56 | $1.3M |
| Jun 3, 2026 | Qingqing Yi | Director | Sale | 235 | $279.13 | $65.6K |
| May 27, 2026 | Alessandro Riva | Director | Sale | 212 | $309.51 | $65.6K |
| May 27, 2026 | Margaret Dugan | Director | Sale | 212 | $309.60 | $65.6K |
Showing the 25 most recent of 282 Form 4 filings for BeOne Medicines Ltd..
Most active ONC insiders
- John Oyler56 filings
- Jane Huang43 filings
- Xiaobin Wu39 filings
- Xiaodong Wang38 filings
- Lai Wang23 filings
Ask anything about ONC insider activity
Use Trabud's AI agent to query BeOne Medicines Ltd.'s Form 4 history in plain English — "Show me ONC CEO purchases this year" or compare it against any other ticker.
Open the AI agentONC insider trading FAQ
Are BeOne Medicines Ltd. insiders buying or selling?
Across 282 SEC Form 4 filings, BeOne Medicines Ltd. (ONC) insiders reported 2 open-market purchases totaling $677.9M and 280 sales totaling $6.3B. That is a net selling position of $5.6B.
How many insiders trade ONC stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BeOne Medicines Ltd.. The most recent filing was accepted on Jul 17, 2026.
Where does Trabud get ONC insider trading data?
All ONC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.